Immunohistochemical analysis of 637 ccRCC tissue samples revealed a negative correlation between expression of SMAD3 and SMAD4, and the age of patients, nuclear grade, tumor size, as well as pTNM stage. This evidence concerns the gene SMAD3 and nonpapillary renal cell carcinoma.